Home visits by teams led by registered nurses or lay health workers can reduce costs and utilization of services, such as emergency department visits and hospitalizations, according to a paper published in Health Affairs.
Home visits by teams led by registered nurses or lay health workers can also reduce costs and utilization of services, such as emergency department (ED) visits and hospitalizations, according to a paper published in Health Affairs.
Past research on home-based care has focused on care delivered by teams led by primary care providers. The current study evaluated the effectiveness of 5 home visit models under the Health Care Innovation Awards of CMS. The models used patient-extender teams to provide care to Medicare beneficiaries and address aspects of service delivery not based in primary care.
“Home visits offer an opportunity to reach high-risk, high-needs patients before a change in condition necessitates a higher level of care and can mitigate access barriers such as lack of transportation or limited mobility,” the authors wrote.
The models studied were:
The 5 models addressed 6 categories of needs: care coordination, beneficiary or caregiver education, referrals to home and community-based services and supports, disease management, advance care planning, and environmental assessment or redesign.
The researchers determined that 4 of the models reduced total Medicare expenditures or utilization. CAPABLE reduced total expenditures relative to comparators and reduced readmissions and observation stays. DASH had significant reductions in ED visits and hospitalizations. AIM had a significant reduction in hospitalizations and Medicare expenditures in the last 30 days of life. Stroke Mobile significantly reduced readmissions. No significant findings were observed for ABC.
“Though the models shared key components related to care coordination and patient/consumer engagement, given the models’ diversity in target populations, staffing, and set of components, it is important to consider each home visit model on its own terms," the author concluded. "The similarities among models that were correlated with positive findings present a strong case for considering the value of having practice extenders provide home visits."
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More